Genzyme opens new research center in Framingham
Genzyme opens new research center in Framingham Save Email Print
Posted: 12:25 PM Sep 22, 2008
Last Updated: 12:25 PM Sep 22, 2008

A | A | A

FRAMINGHAM, Mass. (AP) -- Genzyme Corp. has opened a new 180,000-square foot science center in Framingham where researchers will work on discovering new treatments for a range of ailments including Parkinson's disease, cancer and heart disease.

The Cambridge-based biotechnology company opened the facility Monday. It is expected to employ up to 350 people.

Researchers at the center will focus on medical areas including genetic, immune, kidney and cardiovascular diseases, endocrinology and neurological disorders.

The facility meets federal "green building" standards and uses an estimated 26 percent less energy and 40 percent less water than a comparable conventional building.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

More Stories
How safe and effective are sunscreens?

Tennessee labs test for more disease than normal

HPV vaccine for men?

Volunteering for medical research

New HIV map finds cases heavy in the South

FDA says Zicam nasal spray can cause loss of smell

Local healthcare reform debate

WHO raising H1N1 flu alert to highest level.

Post Your Comments
First Name:
Location:
Enter Comments: characters left
Email (optional):
By posting this comment I have read and agree to the Terms of Use and Privacy Policy:
You must agree to the Terms of Service to continue.
Currently
Local Radar
Radar